Clinical Trial Update: Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase 3 trial update on AT-001 for diabetic cardiomyopathy reports safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Cardiomyopathy

Drugs mentioned

• AT-001 (AT-001)

Snippet

Sponsor: Applied Therapeutics, Inc. | Conditions: Diabetic Cardiomyopathies | Phase 3 | Status: ACTIVE_NOT_RECRUITING